Linked e-resources
Details
Table of Contents
Part I: From Hodgkin?s disease to Hodgkin Lymphoma: Epidemiology
The role of viruses in the genesis of Hodgkin Lymphoma
Pathology and molecular pathology of Hodgkin Lymphoma
Microenvironment, cross-talk and immune escape mechanisms
What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? Part II: Diagnosis and treatment:Clinical evaluation
Functional imaging
Prognostic factors
Principles of radiation techniques in Hodgkin Lymphoma
Principles of chemotherapy in Hodgkin Lymphoma
Treatment of early favorable Hodgkin Lymphoma
Treatment of early unfavorable Hodgkin Lymphoma
Treatment of advanced-stage Hodgkin Lymphoma
Relapsed and refractory Hodgkin Lymphoma
Paediatric Hodgkin Lymphoma. Part III: Special Clinical Situations: Lymphocyte-predominant Hodgkin Lymphoma
The management of Hodgkin Lymphoma during pregnancy
The management of HIV-Hodgkin Lymphoma
The management of elderly patients with Hodgkin Lymphoma
Allogeneic transplantation for relapsed of Hodgkin Lymphoma
Targeting CD 30
Other new agents for patients with Hodgkin Lymphoma. Part IV: Survivorship: Quality of Life in Hodgkin Lymphoma
Second malignancy risk after treatment of Hodgkin Lymphoma
Cardiovascular and pulmonary late effects
Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients. .
The role of viruses in the genesis of Hodgkin Lymphoma
Pathology and molecular pathology of Hodgkin Lymphoma
Microenvironment, cross-talk and immune escape mechanisms
What will we learn from Genomics and Proteomics in Hodgkin Lymphoma? Part II: Diagnosis and treatment:Clinical evaluation
Functional imaging
Prognostic factors
Principles of radiation techniques in Hodgkin Lymphoma
Principles of chemotherapy in Hodgkin Lymphoma
Treatment of early favorable Hodgkin Lymphoma
Treatment of early unfavorable Hodgkin Lymphoma
Treatment of advanced-stage Hodgkin Lymphoma
Relapsed and refractory Hodgkin Lymphoma
Paediatric Hodgkin Lymphoma. Part III: Special Clinical Situations: Lymphocyte-predominant Hodgkin Lymphoma
The management of Hodgkin Lymphoma during pregnancy
The management of HIV-Hodgkin Lymphoma
The management of elderly patients with Hodgkin Lymphoma
Allogeneic transplantation for relapsed of Hodgkin Lymphoma
Targeting CD 30
Other new agents for patients with Hodgkin Lymphoma. Part IV: Survivorship: Quality of Life in Hodgkin Lymphoma
Second malignancy risk after treatment of Hodgkin Lymphoma
Cardiovascular and pulmonary late effects
Gonadal dysfunction and fertility preservation in Hodgkin Lymphoma patients. .